Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Seborrhoea
ADR ID BADD_A03949
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.07      Sebaceous gland disorders
23.02.07.001      Seborrhoea
Description A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS. [MeSH]
MedDRA Code 10039792
MeSH ID D012628
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Salve face | Seborrhea | Seborrhea capitis | Seborrhoea | Skin greasy | Skin seborrheic | Skin seborrhoeic | Oily skin | Oily scalp | Oily hair | Seborrhoea capitis | Greasy hair | Dermatitis, Seborrheic | Dermatitides, Seborrheic | Seborrheic Dermatitides | Seborrheic Dermatitis | Dermatitis Seborrheica
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01834Prednisone--
BADD_D01888Quetiapine--
BADD_D01889Quetiapine fumarate--
BADD_D01909Ramipril0.000093%
BADD_D01951Risperidone--
BADD_D01966Ropinirole--
BADD_D02047Sodium oxybate0.001824%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02171Testosterone cypionate--
BADD_D02192Thalidomide--
BADD_D02236Tofacitinib0.005931%
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02308Trovafloxacin mesylate--
BADD_D02329Valproic acid--
BADD_D02440Lisdexamfetamine0.000153%
The 3th Page    First    Pre   3    Total 3 Pages